CLLS Latest Press Releases

-- April 13, 2026 --

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis' Allogeneic CAR-T Platform Globe Newswire 4:30 PM

-- March 12, 2026 --

Cellectis to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 Globe Newswire 4:30 PM

-- January 8, 2026 --

Cellectis Announces 2026 Strategy and Catalysts Globe Newswire 4:30 PM

-- December 15, 2025 --

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis Globe Newswire 5:39 PM

Cellectis Announces Arbitral Decision in Dispute with Servier Globe Newswire 4:51 PM

-- December 8, 2025 --

ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL Globe Newswire 1:30 AM

-- November 19, 2025 --

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells Globe Newswire 6:18 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software